+ Treg cells were isolated from thymus tissue of normal mice and the spleens of AD mice. Membrane proteins were extracted, and quantitative proteomics labeling with Tandem Mass Tags (TMT) was performed, followed by one-dimensional liquid chromatography/tandem mass spectrometry analysis. Results: Using TMT labeling, we identified 510 proteins, including 63 membrane proteins and 16 plasma membrane proteins. CD47 was one of the upregulated proteins in Treg cells in AD spleens. Although CD47 was expressed in all CD4 + and CD8 + T cells, a significantly higher expression of CD47 was observed in the Treg cells of AD mice and AD patients than in those of normal mice and healthy controls. Furthermore, Treg cells from the spleen showed a significantly higher expression of CD47 than those from the thymus. Conclusion: We found that CD47 is highly expressed in the Treg cells of AD mice, particularly in the spleen. Based on our results, we propose that CD47 high Treg cells are likely induced Treg cells and that upregulated CD47 in the Treg cells of AD patients may play a role in the increased population of Treg cells in AD.
INTRODUCTION
Atopic dermatitis (AD) is a highly pruritic, chronic relapsing inflammatory skin disease characterized by dry itchy skin. 1 An imbalance of Th1 and Th2 immune responses plays a critical role in the pathogenesis of AD. [2] [3] [4] CD25 + CD4 + regulatory T (Treg) cells are key modulators of self-tolerance and immune homeostasis via the suppression of excessive immune responses. 5, 6 Treg cells have been reported to play an important role in many autoimmune and allergic diseases. 7 In AD patients, Treg cells are increased compared to healthy controls. 8, 9 In addition, an elevation of Treg cells correlates significantly with AD severity. 10, 11 While Treg cells in AD patients have an immunosuppressive function similar to those in healthy controls, CCR6 + Treg cells in AD promote a Th2 immune response. 12, 13 The underlying reason for the increase of Treg cells in AD and the function of these cells in AD pathogenesis, however, remain unclear.
In this study, we sought to identify proteins that are differentially expressed in peripheral induced Treg cells in AD and in naturally derived Treg cells in the thymus. We employed the 14 TMT labeling enables genome-wide quantification of protein expression levels as well as the identification and analysis of a small fraction of the proteins, such as membrane proteins, from the whole proteome.
Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
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MATERIALS AND METHODS

Induction of AD skin lesions in NC/Nga mice using Dermatophagoides farinae ointment
Six-week-old female NC/Nga mice were purchased from Central Lab Animal Incorporation (Seoul, Korea) and housed under specific pathogen-free conditions with a stable temperature (22±3°C) and humidity (55±15%). After a week of stabilization, the hair on the back was removed using electric clippers and hair removal cream. One day after hair removal, 150 μL of 4% sodium dodecyl sulfate (SDS) was topically applied to disrupt the skin barrier. Two hours later, Biostir AD cream [Dermatophagoides farinae (D. farinae) body extracts, Biostir, Kobe, Japan] was applied to the dorsal surface. The removal of hair, application of SDS, and treatment using Biostir AD cream were repeated twice a week for 8 weeks. NC/Nga mice without dust mite application were used as a control group.
Evaluation of AD severity
The severity of AD-like skin lesions was measured using the SCORAD index for mice. This index ranges from 0 to 12. In brief, the SCORAD index includes scores based on the presence of erythema or hemorrhage, scarring or dryness, excoriation or erosion, and edema. Each symptom was graded on a scale of 0 to 3 (0, none; 1, mild; 2, moderate; and 3, severe). The score was the sum of individual item scores. The severity of dermatitis was assessed once weekly by two independent researchers.
Enzyme-linked immunosorbent assay (ELISA) for total serum IgE
Total immunoglobulin E (IgE) levels in serum were measured with an enzyme-linked immunosorbent assay (ELISA) MAX TM Deluxe Set (BioLegend, San Diego, CA, USA) in accordance with the manufacturer's instructions. In brief, wells of a 96-well plate were coated with an IgE-specific monoclonal antibody and then incubated overnight at 4°C. Standards and serum samples were added to the plate, which was then incubated at room temperature for 2 h. Captured IgE molecules were detected using biotinylated anti-mouse IgE detection antibody. Avidin-horseradish peroxidase was subsequently added, followed by TMB substrate solution. Absorbance (as optical density) of each well was measured at 450 nm with a microplate reader.
Preparation of splenocytes and thymocytes using high-gradient magnetic cell sorting (MACS)
To identify differentially expressed proteins in peripheral induced Treg cells in AD and in naturally derived Treg cells in normal controls, CD4 + CD25 + Treg cells were isolated from thymus tissue of normal mice and the spleens of AD mice. The spleen and thymus were removed from each mouse and disrupted using a syringe plunger to prepare a cell suspension. Blood cells were lysed using blood cell lysis buffer (Sigma-Aldrich, St 
Membrane protein extraction
Isolated Treg cells were centrifuged at 850×g for 2 min, and the supernatant was then removed. Membrane proteins were extracted using a Mem-PER TM Eukaryotic Membrane Protein Extraction Reagent Kit (Thermo Scientific, Waltham, MA, USA). In brief, Reagent A was added to the pellet in order to lyse the cells. Two parts Reagent C along with one part Reagent B was then added, and after centrifugation and incubation, the hydrophilic top layer was discarded.
TMT labeling for proteomic analysis
After membrane protein extraction, 100 μg of protein was equally divided into two halves and labeled with two different TMT reagents (Thermo Scientific) following the manufacturer's standard protocol. The membrane protein samples from the spleens of six-week-old AD mice were labeled with TMT-126 and TMT-130, whereas those from the thymuses of normal mice were labeled with TMT-127 and TMT-131. The four samples labeled with different TMT reagents were mixed, dried, and then re-solubilized with water containing 0.5% formic acid for one-dimensional liquid chromatography/tandem mass spectrometry (1DLC/MS/MS) analysis.
Nano-LC-MS/MS analysis
The resultant peptides were analyzed using 1DLC-MS/MS. Peptides were identified using MS/MS with a nano-LC-MS system consisting of a Nano Acquity U7PLC system (Waters, Milford, MA, USA) and an LTQ Orbitrap elite mass spectrometer (Thermo Scientific) equipped with a nanoelectrospray source. An autosampler was used to load 5-μL aliquots of the peptide solutions onto a C18 trap-column (i.d. 300 μm, length 5 mm, and particle size 5 μm; Waters). The peptides were desalted and concentrated on the column at a flow rate of 5 μL/min. Then, the trapped peptides were back-flushed and separated on a 200-mm homemade microcapillary column, consisting of C18 matrix (Aqua; particle size 3 μm) packed into 100-μm silica tubing with an orifice i.d. of about 6 μm. The mobile phases, A and B, were composed of 0 and 100% acetonitrile, respectively, and each contained 0.1% formic acid. The LC gradient began with 5% B for 5 min and was increased to 15% B over 5 min, to 50% B over 100 min, and then to 95% B over 5 min, at which point it remained at 95% B for 5 min and then decreased to 5% B for another 5 min. The column was re-equilibrated to 5% B for 15 min before the next run. The voltage applied to produce the electrospray was 2.2 kV. During the chromatographic separation, the LTQ Orbitrap Elite was operated in a data-dependent mode under direct control of Xcalibur software (Thermo Scientific). The MS data were acquired using the following parameters: 10 data-dependent collision-induced dissociation (CID) MS/MS scans per every full scan in label-free mode; 10 data-dependent higher energy collision-induced dissociation (HCD) MS/MS scans per every full scan in TMT; CID scans acquired in LTQ with two-microscan averaging; full scans and HCD scans acquired in Orbitrap at the resolutions of 30000 and 15000, respectively, with two-microscan averaging; 35% normalized collision energy in CID and in HCD; ±1.5-Da isolation window; and dynamic exclusion enabled with a ±1.5-Da exclusion window. All 1DLC-MS/MS analyses for TMT-labeling quantification were performed in duplicate for each sample.
Data analysis
A probability-based (and error-tolerant) protein database search of MS/MS spectra against the latest IPI rat protein database (IPI rat v3.70) was performed using a local MASCOT server (2.3, Matrix Science, London, UK) to identify and quantify the analyzed proteins. The rate of decoy hits in the combined forward and reverse database was less than 1% of the forward hits at both the peptide and the protein levels in each of these experiments. The following search criteria were used: 20 ppm precursor ion mass tolerance; 0.5-Da product ion mass tolerance; two missed cleavages; trypsin as the enzyme; TMT modification at the N-terminus and lysine residues as well as carbamidomethylation at the cysteine residues as static modifications; oxidation at methionine; phosphorylation at serine, threonine, and tyrosine as variable modifications; an ion score threshold of 20; and TMT-6 plex for quantification. Quantification was based on the averaged signal-to-noise ratio of TMT reporter product ions of more than two unique peptides. In TMT experiments, reporter ions for peptide identification were extracted from small windows (±20 ppm) around their expected m/z in the HCD scan. As a single sample was individually labeled with two TMT reagents, peptides with similar ratios in the comparison of the intensity of reporter ions within 30% were selected for protein quantitation. The abundance ratio of a protein was estimated using the ratio between the total intensities of 12 proteins in different reporter ion channels. Given the distributions of protein log2 ratios, proteins showing ≤-0.4 or ≥0.4 were considered to be differentially expressed.
Human samples
Human blood samples were obtained from three non-AD healthy controls and from four AD patients who were diagnosed according to the criteria of Hanifin and Rajka. 15 The Institutional Review Board approved this study (IRB no: 4-2013-0624), and all subjects provided written informed consent to participate in the study. PBMCs from the subjects were isolated by centrifugation on a Lymphoprep gradient (density 1.077 g/mL) and centrifuged at 800×g for 15 min at 4°C. Cells from the interphase were then washed three times with phosphatebuffered saline (PBS) containing 5 mM EDTA. Isolated PBMCs were used for flow cytometric analysis.
Flow cytometry
Cells were washed with PBS and stained with a fixable viability dye. After washing, cells were labeled at 4°C for 30 min with anti-CD3, -CD4, -CD8, and -CD25 antibodies conjugated with fluorescent dye (eBioscience, San Diego, CA, USA), anti-CD47 (eBioscience), and PerCP-Cy5.5 anti-rat secondary antibody. For intracellular labeling, cells were fixed and permeabilized with cytofix/cytoperm buffer (eBioscience) and labeled with anti-human FOXP3 antibody (eBioscience) conjugated with FITC. Labeled cells were quantified using a BD FACSVerse flow cytometer, and the data were analyzed using FlowJo Software (BD Bioscience, San Jose, CA, USA).
Western blotting
After membrane protein extraction as described above, equal amounts of cellular proteins were mixed with 5x sample buffer and heated at 100°C for 5 min. Proteins were then resolved on an 8% SDS-polyacrylamide gel. After electrophoresis, the proteins were transferred onto an ECL nitrocellulose membrane (GE Healthcare, Buckinghamshire, UK) using Tris buffer [0.025 M Tris-HCI (pH 6.8), 0.192 M glycine, and 20% MeOH]. The membrane was blocked for 1 h at room temperature with 5% skim milk in TBS-Tween 20, incubated overnight at 4°C with anti-CD47 antibody (BD Bioscience) and anti-GAPDH antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and then incubated with horseradish peroxidase-conjugated antirat secondary antibody (Santa Cruz Biotechnology) for 1 h at room temperature. Finally, the membrane was developed using enhanced chemiluminescence Western blotting detection reagents (Santa Cruz Biotechnology) and quantified via densitometry.
Statistical analyses
A one-way ANOVA was used to assess the SCORAD results ( Fig.  1B ) and CD47 expression in NC/Nga mice ( Fig. 3B and D) . Bonferroni correction was used for post-hoc analysis. A two-way ANOVA was used to assess the results for serum total IgE (Fig.  1C) . Pearson correlation was used for the analysis of CD47 expression in AD patients (Fig. 4C ). Deviations were considered statistically significant when p<0.05.
RESULTS
AD-like skin lesions induced by application of D. farinae topical ointment in mice
Mild erythema was observed following a 2-week application of D. farinae ointment, and significant scarring and crusts were observed after 3 weeks of topical application of D. farinae extracts (Fig. 1A) . The SCORAD scores exhibited a rapid and significant increase, with the highest score (7.8±0.73) noted after 6 weeks of D. farinae treatment. After the 6 weeks of D. farinae ointment treatment, a slight improvement in the skin was observed, and the SCORAD score decreased to 5.5±1.19 at 8 weeks of D. farinae topical application (p<0.001) (Fig. 1B) .
In accordance with the clinical findings, repeated topical application of D. farinae caused a significant increase in serum IgE levels in NC/Nga mice compared to normal mice. The serum IgE level was 53±8.8 ng/mL after 2 weeks of application, and it increased at the 4-and 6-week time points before reach- ing a plateau (525.4±12.4 ng/mL after 4 weeks and 679.2±20.1 ng/mL after 6 weeks; p<0.001) (Fig. 1C) .
Isolation of CD4 +
CD25 + Treg cells
To identify Treg cells specifically involved in AD pathogenesis, we isolated CD4 + CD25 + T cells from AD spleens and normal thymuses with 80% purity. More than 90% of these cells expressed Foxp3, suggesting that these cells were Treg cells (Fig.  1D) . Thus, we analyzed the cell surface proteins from these purified cells using TMT-labeling proteomic analysis.
Protein identification using TMT-label proteomic analysis
Quantification of 510 proteins was achieved via LC-MS/MS analysis and based on the peak area of precursor ions of identified peptides. Among the 510 quantified proteins, 63 were membrane proteins (Table 1) , and 16 were plasma membrane proteins (Table 2) . Considering the distributions of the protein log2 ratios, proteins that exhibited values of ≤-0.4 or ≥0.4 were considered to be differentially expressed. These criteria allowed for the identification of six upregulated proteins, including H-2 class II histocompatibility antigen, h-2 class I histocompatibility antigen K-W28 alpha chain-like isoform 1, D-P alpha chain-like isoform 4, protein tyrosine phosphatase receptor type C-associated protein, isoform 3 of receptor-type tyrosine-protein phosphatase C, and isoform 1 of the leukocyte surface antigen CD47 (Table 2) these, CD47 has been reported to be associated with immune regulation, particularly T cell costimulation 16 and phagocytosis. 17, 18 Therefore, we further evaluated CD47 expression in Treg cells.
Validation of CD47 expression in Treg cells
CD47 was expressed in all CD4
+ T cells and CD8 + T cells ( Fig.  2A) . In addition, 99% of the CD4
+ Treg cells also expressed CD47 (Fig. 2B) , and there was no difference between AD mice and control mice. However, the expression level of CD47 was significantly higher in Treg cells from the AD mice than in those from the control mice (Fig. 3A) . Moreover, its expression was much higher in Treg cells from the AD spleens than in those from the AD thymuses (Fig. 3B) . Increased expression of CD47 in the Treg cells of AD mice relative to controls, especially in the spleen, were also confirmed on Western blot analysis ( Fig. 3C and D) .
Increased CD47 expression in Treg cells of AD patients
To provide support for the mice data results, the expression of CD47 was also analyzed in human PBMC. All CD4 + CD25 + Foxp3 + Treg cells expressed CD47 in both AD and healthy controls (Fig. 4A ). However, the expression level of CD47 was higher in Treg cells in AD than in healthy controls (Fig. 4B) . We also analyzed the correlation of the expression level of CD47 with AD severity. The expression of CD47 in Treg cells showed positive correlation with AD severity measured via EASI score (Pearson correlation r=0.84) (Fig. 4C ). Higher levels of CD47 were shown to correlate significantly more severe AD.
DISCUSSION
Proteomics is the systematic analysis of protein profiles in a biological sample. Considering the discrepancies among profiles of genes, RNA transcripts, and proteins, proteomics is an ideal tool for the identification of new biomarkers, as the proteins are the main actors in the ongoing pathophysiology of a disease. The gel-free TMT approach uses isobaric labels to allow the genome-wide quantitation of the proteome. We em- ployed this method to identify differentially expressed membrane proteins in induced Treg cells in AD. We initially induced AD-like skin lesions in NC/Nga mice using D. farinae ointment for 8 weeks and then utilized ELISA to measure the induced serum IgE to pinpoint the optimal time for proteomics analysis. After the application of D. farinae for 6 weeks, severe AD-like skin lesions appeared on the dorsal skin of the NC/ Nga mice. Total IgE in the serum markedly increased and reached a plateau after 6 weeks of application of D. farinae. Based on these findings, mice treated for 6 weeks with D. farinae were used for proteomic analysis of membrane proteins in Treg cells. With the TMT-labeling method, we quantitated 510 proteins and ultimately identified six significantly upregulated plasma membrane proteins, including CD47, expressed in the Treg cells of AD mice.
CD47, an immunoglobulin-like protein, interacts functionally with integrins, 19 thrombopondin-1, 20 and signal regulatory protein α (SIRPα). 18, 19 This factor has been implicated in the regulation of neutrophil migration, 21 axon extension, 22 T cell costimulation, 16 and phagocytosis. 17, 18 SIRPα/CD47 ligation inhibits phagocytosis by antigen-presenting cells, and a lack of CD47 expression results in the phagocytosis of red blood cells, 18 T cells, 23 and bone marrow cells. 24 CD47 can also be transiently regulated by inflammatory stimuli in hematopoietic stem cells, and the presence of CD47 determines the probability of engulfment in vivo. 23 Thus, CD47 is thought to function as an anti-phagocytosis signal. The thrombospondin-1/CD47 interaction inhibits interleukin (IL)-12 production by dendritic cells, 25, 26 IL-12 responsiveness, 27 and Th1 differentiation. 24, 28 Furthermore, CD47 promotes the differentiation of Treg cells 29 and reg- ulates activated CD103 + Treg cell homeostasis; 30 however, a deficiency of CD47 does not alter the inhibitory function of Treg cells. 30 We showed in this study that CD47 expression was significantly higher in peripheral Treg cells in AD mice, particularly in spleen samples. Considering the function of CD47 as a signal of anti-phagocytosis and the increased population of Treg cells in AD patients, increased expression of CD47 in peripheral Treg cells in AD might expand the life span of these cells and result in the increased population of Treg cells in AD.
Treg cell populations primarily fall into two categories: naturally occurring Treg (nTreg) cells, which constitutively express Foxp3, and induced Treg (iTreg) cells, which are induced in the periphery by antigen stimulation or under tolerogenic conditions. 10, 31 These iTreg cells can be expanded and differentiated from nTreg cells or from CD4 + CD25
-effector T cells after stimulation by cytokines. 10, 32, 33 Several experiments were conducted by a number of groups to determine the developmental and functional differences between nTreg and iTreg cells. [34] [35] [36] Haribhai, et al. 35 revealed a large number of transcripts that were differentially expressed between iTreg cells and nTreg cells. In other studies, Ikzf2 (Helios) and Nrp1 (neuropilin-1) expression were found to be more enhanced in nTreg cells than in iTreg cells, and these studies suggested that Helios may serve as a possible marker for nTreg cells. 37, 38 In our study, CD47 was more highly expressed in Treg cells from spleens than in those from thymuses in normal mice, and its expression was much higher in spleens from AD mice. However, there was no significant difference in CD47 expression in Treg cells from thymuses between normal and AD mice. Considering that most Treg cells in the thymus are nTreg cells and that those from the spleen are composed of both nTreg cells and iTreg cells, we suggest that CD47 high Treg cells are likely iTreg cells and that the status of CD47 expression may be a marker that differentiates iTreg cells from nTreg cells.
In this study, we found that CD47 expression was upregulated in Treg cells in AD. Although CD47 is a ubiquitous membrane protein, increased expression of this factor in AD may play a role in the increased population of Treg cells and the consequent dominant Th2 immune response in AD. Further investigation will be necessary to determine the precise functional role of CD47 in Treg cells and to validate this factor as a differential marker between iTreg cells and nTreg cells; however, in this study, we clearly showed an increased expression of CD47 in peripheral Treg cells of both AD mice and AD patients, suggesting that CD47 is a valuable candidate molecule.
